HR Execs on the Move

Pacira Pharmaceuticals

www.pacira.com

 
Pacira Pharmaceuticals, Inc. (Nasdaq: PCRX) is an emerging specialty pharmaceutical company focused on the clinical and commercial development of new products that meet the needs of acute care practitioners and their patients. The company`s current emphasis is the development of non-opioid products for postsurgical pain control, and its lead product, EXPAREL® (bupivacaine liposome injectable suspension), was commercially launched in the United States in April 2012. EXPAREL and two other products have utilized the Pacira proprietary product delivery technology DepoFoam®, a unique platform that encapsulates drugs without altering their molecular structure and then releases them over a desired period of time.
  • Number of Employees: 250-1000
  • Annual Revenue: $100-250 Million
  • www.pacira.com
  • 5 Sylvan Way
    Parsippany, NJ USA 07054
  • Phone: 973.254.3560

Executives

Name Title Contact Details
Dean Maddox
Sr. Manager CMO Operations Profile
Lynette Bowman
VP HR Profile
Paul Maccaro
Director Talent Management and Leadership Development Profile
Timothy Biggiani
Director Talent Acquisition Profile

Similar Companies

Story County Medical Center

Story County Medical Center is full-service, primary-care medical center dedicated to providing you high quality healthcare in a community-oriented manner. We value personal service, open communications, a team approach to your care and the relationships built along the way.

Blue Elm

Blue Elm is a Westwood, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Hyperion Technology Group

Hyperion Technology Group is a defense and space company based in Madrid, Spain.

Portola

Portola Pharmaceuticals is dedicated to developing and commercializing therapies that transform patient lives and advance patient care by changing treatment paradigms in thrombosis and other hematologic diseases. Our two lead assets are Bevyxxa® (betrixaban), and andexanet alfa. In addition, cerdulatinib is our investigational Syk/JAK inhibitor to treat hematologic cancers. These compounds come from our own internal research efforts and represent important advances to address significant unmet needs. We are employing novel strategies that may increase the likelihood of clinical, regulatory and commercial success of our potentially lifesaving therapies.

3Fifteen Primo Cannabis

Shop Premium Marijuana at 3Fifteen Dispensaries in Missouri. Browse Our Full Medi & Rec Cannabis Products Menu & Order Pickup Today!